Skip to main content

Genus Capital Management Inc.

Position in JNJ — Johnson & Johnson

CIK 1532385 VANCOUVER, A1

Position in JNJ

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$12,407,196
-$1,265,555 QoQ
Shares Held
48,853
-12.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#980
of 4,663 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$224,161
PutShares
1,550

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names. JNJ ranks #2 (26.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 JNJ
Johnson & Johnson
This page
48,853 $12,407,196

All Filings in JNJ

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,407,196 48,853
2026-03-31 $13,672,751 55,935
2025-12-31 $11,288,708 54,548
2025-09-30 $2,026,826 10,931
2025-06-30 $212,322 1,390
2025-03-31 $243,784 1,470
2024-12-31 $224,161 1,550
2024-09-30 $251,193 1,550
2024-06-30 $226,548 1,550
2024-03-31 $289,487 1,830
2023-12-31 $296,238 1,890
2023-09-30 $1,211,735 7,780
2023-06-30 $371,095 2,242